Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Meet Aranoa by Aranui Cruises, the Newest Way to Explore the Untouched Austral Islands (PR Newswire) +++ IMMERSION Aktie +3,45%

CHARLES RIVER Aktie

 >CHARLES RIVER Aktienkurs 
142.05 EUR    -8.3%    (Tradegate)
Ask: 142.85 EUR / 150 Stück
Bid: 142 EUR / 150 Stück
Tagesumsatz: 38 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>CHARLES RIVER Performance
1 Woche: -9,8%
1 Monat: +0,6%
3 Monate: +5,2%
6 Monate: +42,5%
1 Jahr: -8,9%
laufendes Jahr: -14,1%
>CHARLES RIVER Aktie
Name:  CHARLES RIVER LAB.
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US1598641074 / 939391
Symbol/ Ticker:  RV6 (Frankfurt) / CRL (NYSE)
Kürzel:  FRA:RV6, ETR:RV6, RV6:GR, NYSE:CRL
Index:  S&P500
Webseite:  http://www.criver.com
Profil:  Charles River Laboratories International, Inc. is ..
>Volltext..
Marktkapitalisierung:  7660.7 Mio. EUR
Unternehmenswert:  9917.39 Mio. EUR
Umsatz:  3506.07 Mio. EUR
EBITDA:  790.04 Mio. EUR
Nettogewinn:  -60.25 Mio. EUR
Gewinn je Aktie:  -1.14 EUR
Schulden:  2427.22 Mio. EUR
Liquide Mittel:  159.46 Mio. EUR
Operativer Cashflow:  685.31 Mio. EUR
Bargeldquote:  0.17
Umsatzwachstum:  -10.17%
Gewinnwachstum:  -114.39%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  CHARLES RIVER
Letzte Datenerhebung:  05.11.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 49.21 Mio. St.
Frei handelbar: 98.88%
Rückkaufquote: 5.22%
Mitarbeiter: 20100
Umsatz/Mitarb.: 0.18 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 4.64%
Bewertung:
KGV: -
KGV lG: 17.53
KUV: 2.12
KBV: 2.68
PEG-Ratio: -
EV/EBITDA: 12.55
Rentabilität:
Bruttomarge: 29.96%
Gewinnmarge: -1.72%
Operative Marge: 11.86%
Managementeffizenz:
Gesamtkaprendite: -0.89%
Eigenkaprendite: -1.96%
>Peer Group

Es sind 597 Aktien bekannt.
 
05.11.25 - 17:48
Charles River Labs übertrifft Prognosen, doch Aktie fällt deutlich (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 16:45
Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
 
While the top- and bottom-line numbers for Charles River (CRL) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....
05.11.25 - 16:00
Charles River Laboratories (CRL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
 
Charles River (CRL) delivered earnings and revenue surprises of +4.74% and +2.06%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
05.11.25 - 14:49
Charles River Laboratories Updates FY25 Earnings Outlook (AFX)
 
WASHINGTON (dpa-AFX) - Charles River Laboratories International, Inc. (CRL), Wednesday an updated financial outlook for fiscal year 2025.The company now anticipates earnings of $4.15 - $4.35 per s......
05.11.25 - 14:49
Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
 
WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) reported a profit for third quarter that Decreased from last year but beat the Street estimates.The company's bottom line......
05.11.25 - 13:12
Charles River Laboratories Non-GAAP EPS of $2.43 beats by $0.09, revenue of $1B beats by $9.21M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.11.25 - 13:03
Charles River Laboratories Announces Third-Quarter 2025 Results (Business Wire)
 
– Third-Quarter Revenue of $1.00 Billion – – Third-Quarter GAAP Earnings per Share of $1.10 and Non-GAAP Earnings per Share of $2.43 – – Updates 2025 Guidance – WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2025. For the quarter, revenue was $1.00 billion, a decrease of 0.5% from $1.01 billion in the third quarter of 2024. The impact of foreign currency translation increased reported revenue by 1.3%, and the divestiture of a small Safety Assessment site in 2024 reduced reported revenue by 0.2%. Excluding the effect of these items, revenue declined 1.6% on an organic basis. On a segment basis, lower revenue in the Discovery and Safety Assessment (DSA) and Manufacturing Solutions (Manufacturing) segments were partially offset by organic revenue growth in the Research Models and Services (RMS) segment. In the third quarter of 2025, the GAAP operating margin increased to 13.3% from 11.6% in the thi...
04.11.25 - 18:03
Charles River Laboratories Q3 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.11.25 - 14:36
Charles River Associates (CRA) Strengthens Its Antitrust & Competition Economics Practice (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Nate Goldstein has joined CRA as a Vice President in the Antitrust & Competition Economics Practice. “We are pleased to welcome Nate to CRA's Antitrust & Competition Economics Practice,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “He is a skilled leader who has managed teams of experts in dozens of complex and high-profile antitrust investigations during his notable career working for the Justice Department.” “Having led more than 150 federal investigations, Nate has a rare combination of subject matter expertise, executive talent, and practical experience that is prized by CRA and our clients,” said Margaret Sanderson, CRA Vice President and Global Practice Leader of the Antitrust & Competition Economics Practice. “We look forward to working with him to help our clients naviga...
30.10.25 - 13:09
Charles River Associates (CRA) Reports Financial Results for the Third Quarter of 2025 (Business Wire)
 
Broad-based Contributions Drive Strong Revenue and Profit Growth Company Raises Revenue Guidance and Increases Lower End of Profit Guidance for Full-Year Fiscal 2025 Company Increases Quarterly Dividend by 16%BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fiscal third quarter ended September 27, 2025. “CRA continued its run of strong results into the third quarter of fiscal 2025 as revenue increased by 10.8% year over year to $185.9 million,” said Paul Maleh, CRA's President and Chief Executive Officer. “Our performance during the quarter was broad-based, with seven of eleven practices growing year over year. Our Antitrust & Competition Economics, Energy, Finance, and Intellectual Property practices each posted double-digit revenue growth. We also generated growth across our geographies, with our North American operations increasing revenue by 6.8% and...
30.10.25 - 13:03
Charles River Associates (CRA) Increases Quarterly Cash Dividend 16% to $0.57 Per Common Share (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that its Board of Directors has declared a 16% increase in the quarterly cash dividend from $0.49 to $0.57 per common share to be paid on December 12, 2025 to shareholders of record of CRA's common stock as of the close of business on November 25, 2025. The Company expects to continue paying quarterly dividends, the declaration, timing and amounts of which remain subject to the discretion of CRA's Board of Directors. About Charles River Associates (CRA) Charles River Associates® is a leading global consulting firm specializing in economic, financial and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combi...
29.10.25 - 16:30
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
 
Charles River (CRL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....
28.10.25 - 13:36
Charles River Associates (CRA) Strengthens Its Antitrust & Competition Economics Practice (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Dr. Keler Marku has joined CRA as a Vice President in the Antitrust & Competition Economics Practice. “We are pleased to welcome Keler back to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “Keler is an expert in industrial organization, microeconomic theory, and data science, with extensive experience related to generative AI competition and IP matters.” “Keler has wide-ranging expertise developing theoretical and econometric models to address complex legal questions in antitrust, mergers, damages, copyright, and other IP matters,” said Margaret Sanderson, CRA Vice President and Global Practice Leader of the Antitrust & Competition Economics Practice. “Technical analysis plays a pivotal role in the outcome of competition and IP cases, and as a CRA alumnus, Keler recognizes th...
28.10.25 - 00:21
HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
 
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Oct. 27, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Charles River Laboratories International,......
23.10.25 - 13:24
What to Expect From Charles River Laboratories′ Q3 2025 Earnings Report (Barchart)
 
Charles River Laboratories is all set to release its fiscal third-quarter earnings next month, and analysts project a low double-digit profit decline....
21.10.25 - 14:36
Charles River Associates (CRA) Expands Its Risk, Investigations & Analytics Practice (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Andrew Rosini has joined CRA's Risk, Investigations & Analytics Practice as a Vice President. “We are excited to welcome Andrew to CRA,” said Paul Maleh, President and Chief Executive Officer of Charles River Associates. “He brings more than 20 years of experience advising clients involved in complex domestic and international government and internal investigations, with a specific focus on financial crimes and compliance across all financial products. Our clients will benefit from Andrew's expertise in both traditional and decentralized finance, particularly as the cryptocurrency landscape continues to evolve and risk exposures increase.” “Andrew's background in financial crimes and his nuanced understanding of regulatory frameworks complement the expertise within our global team and further enhance the strength of our...
20.10.25 - 20:30
Will Charles River (CRL) Beat Estimates Again in Its Next Earnings Report? (Zacks)
 
Charles River (CRL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....
20.10.25 - 16:36
Confluence Technologies Appoints Bryan Woodard Chief Legal Officer (Business Wire)
 
PITTSBURGH--(BUSINESS WIRE)--Confluence Technologies, Inc. (“Confluence”), a global leader in regulatory, analytics, and investor communications solutions for the investment management industry, today announced the appointment of Bryan Woodard as Chief Legal Officer. Woodard will lead Confluence's global legal strategy and oversee compliance functions, ensuring the company continues to meet evolving regulatory standards while supporting innovation and operational excellence across its suite of solutions. Woodard brings more than two decades of legal and regulatory leadership in the financial services sector, most recently serving as Executive Vice President and Deputy General Counsel at State Street. This included playing a leadership role in multiple international acquisitions and leading the global legal teams responsible for supporting State Street Investor Services, State Street Global Markets, State Street Alpha, and Charles River Development, as well the corporate treasury functions and global ...
20.10.25 - 14:42
meQuilibrium Honors IBM, GE Aerospace, Ford, Citizens, ABB, and Roman Grubbs, PhD, Charles River Labs, for Achievements in Supporting Employee Resilience (PR Newswire)
 
Winners will share keys to optimizing employee well-being and performance during an online resilience panel discussion on October 23 BOSTON, Oct. 20, 2025 /PRNewswire/ -- meQuilibrium (meQ), the global leader in proactive workforce mental health and performance solutions, has announced......
16.10.25 - 14:33
Charles River Associates (CRA) to Host Third-Quarter Fiscal 2025 Financial Results Conference Call on October 30 (Business Wire)
 
Conference Call to be Webcast Live at 10:00 a.m. ETBOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company will webcast its third-quarter 2025 financial results conference call on Thursday, October 30, 2025 at 10:00 a.m. ET. The conference call will be hosted by President and Chief Executive Officer Paul Maleh, Chief Financial Officer Eric Nierenberg, and Chief Corporate Development Officer Chad Holmes. To listen to a live webcast of the call, please visit the “Investor Relations” section of CRA's website at http://www.crai.com. To listen to the call via telephone, dial (877) 709-8155 or (201) 689-8881. Prior to the call, CRA will post the press release announcing its financial results and supplemental financial information, including prepared CFO remarks, on the “Investor Relations” section of its website. An archived version of the webcast, press release, and finan...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!